Owkin Advances AI in Drug Discovery with Launching $50 Million MOSAIC Project
Owkin, an AI biotech firm, is partnering with NanoString Technologies and other notable cancer research institutions to spearhead the MOSAIC …
All Posts
ReproCell, IBM, and HNCDI Debut Pharmacology-AI to Boost Efficiency of Drug Discovery
ReproCell, a well-established life sciences company, recently revealed its latest service offering, Pharmacology-AI. This service is the result of a …
Seqera Labs Joins Forces with Genomics England to Boost Genomic Medicine Research
Seqera Labs, recognized for its secure workflow orchestration software in the life sciences domain, is aligning forces with Genomics England, …
FDA IND Approval of AI-derived Cancer Drug ISM3091 Marks a Milestone for Insilico Medicine
In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …
Eli Lilly Collaborates with XtalPi to Harness AI in Drug Discovery
XtalPi Inc., a company that uses artificial intelligence (AI) and automation in pharmaceutical technology, is set to collaborate with Eli …
Neuralink's Journey and the Broadening Horizons of Brain-Computer Interface Technology
Neuralink, Elon Musk's brain-implant company, has just revealed that it received approval from the U.S. Food and Drug Administration (FDA) …
Valo Therapeutics' Innovative Immuno-Oncology Therapy PeptiCRAd-1 Begins Human Trials
Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …
Mitsubishi VC Arm Leads $7.5M Financing for PharmEnable's AI in Drug Discovery Efforts
PharmEnable, an innovative drug discovery firm, recently secured $7.5M in Pre-Series A financing, reflecting growing confidence in its proprietary AI-based …
How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery
What is "supercomputing"? It refers to processing a massive quantity of complex data-intensive and computation-heavy problems often found in scientific …
FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment
In a noteworthy development in the pharmaceutical industry, SiSaf Ltd, a renowned RNA delivery and therapeutics firm, recently announced that …
LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration
London-based LabGenius, known for its innovative approach to antibody discovery, recently revealed impressive results from its research platform demonstration project. …
The Rising Influence of Machine Learning and Coding in Biotechnology (a Survey)
The landscape of biotechnology is rapidly evolving, with coding and machine learning becoming integral to the innovative processes. A recent …